COVID-19 public health information from the US CDC |
COVID-19 research information from the US NIH |
COVID-19 resources for global health researchers
Congressional appropriators consider Fogarty's impact
May / June 2017 | Volume 16, Issue 3
As the Fiscal Year 2018 budget is being considered by Congress, a number of appropriators have discussed Fogarty's role in global health research.
The Center represents only a sliver of the NIH's budget yet it has "an outsized impact" on the prevention and mitigation of outbreaks in the world, observed Rep. Rosa DeLauro during the recent NIH House appropriations hearing.
"The Fogarty Center has actively increased capacity in countries facing health crises like Ebola. They have trained some of the best practitioners on the ground accelerating discoveries," she continued. "As we have seen with diseases like Ebola, Zika, HIV/AIDS, public health emergencies know no borders."
Dr. Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases also gave a strong endorsement of Fogarty's impact, referring to Fogarty trainees around the world as "our brothers and sisters," who are working in partnership to contain Ebola outbreaks, conduct Zika vaccine trials and address other global threats.
At the earlier House hearing on the HHS budget, Subcommittee Chairman Rep. Tom Cole said he saw value in supporting global health. "You're much more likely to die in a pandemic than a terrorist attack," he said. "I'd much rather fight Ebola in West Africa than in West Dallas."
To view Adobe PDF files,
download current, free accessible plug-ins from Adobe's website.